Vaccpower

Vaccpower is a clinical-stage biotechnology company based in Beijing, China, specializing in the development of innovative recombinant protein vaccines. Founded by industry veterans with extensive experience in vaccine R&D, the company leverages a proprietary technology platform to address significant unmet needs in infectious disease prevention. Its pipeline includes candidates for COVID-19, Human Papillomavirus (HPV), and Herpes Zoster (shingles), with several programs in clinical development. Vaccpower aims to provide high-quality, accessible, and stable vaccine products through its integrated capabilities in research, clinical trials, and large-scale GMP manufacturing. The company is backed by prominent venture capital firms and is positioned as a key player in the emerging Chinese vaccine innovation landscape.